2017 SAPA Annual Conference is Open for Registration

摘要: 2017 SAPA Annual Conference (Sep 29 and 30) is open for registration!

01-12 16:23 首页 SAPA

Sep 29 and 30, 2017

DoubleTree by Hilton

200 Atrium Drive 

Somerset, NJ 08873, USA


Early-bird registration is now open!

Please long-tap the QR code below and select "Scan QR Code in image" to register, or tap "Read more/阅读原文" at the end of this article to register.

Scan to register!

Early registration fee (until 8/31)



Regular registration fee (starting from 9/1)



9/30 Dinner (Seating is limited)



If you have any questions, please contact:


Building upon last year’s record breaking success, this year’s SAPA Annual Conference will be expanded to one and half days – September 29th (Friday) afternoon and September 30th (Saturday). The theme for this year’s conference is “Advancing Pharmaceutical and Biotechnology Development through Global Collaboration: Challenges and Opportunities”.  We have invited many distinguished speakers and professionals who will share their views and address key issues in the following areas:

?Breakthrough therapies for unmet medical needs

?Disruptive innovation for drug discovery and development

?Pharmaceutical investment

?Business development and licensing

?New advances in regulatory sciences

?Intellectual properties – recent high profile case studies

?Career planning, development, and advancement

Preliminary Program

Plenary Sessions

Confirmed Speakers:   

  • Christian Antoni, MD, PhD, VP, Head of Immunology Development, Sanofi

  • Fener Chen, PhD, Member of Chinese  Academy of Science

  • Michael Foley, PhD, Director of Tri-I TDI and Sanders Innovation and Education Initiative

  • Debbie Hart, President and CEO, BioNJ

  • Yiwu He, PhD, MBA, CEO, BGI Groups USA

  • Mathias   Hukkelhoven, PhD, SVP, RegulatorBMS

  • Jeffrey S. Humphrey, MD, CMO and President, Kyowa Kirin Pharma Development, Inc

  • David Ho, PhD, Professor, CEO of Aaron Diamond AIDS Research Center

  • Theresa Mullin, PhD, Director, office of strategic program, FDA/CDER and Chair of ICH management committee, FDA/CDER

Keynote presentations at the plenary sessions will focus on advancing pharmaceutical and biotechnology development through global collaboration, challenges and opportunities on breakthrough and innovative therapies, capital investment, business development strategies, legal protection, and regulatory sciences. These distinguished leaders will share their experience and perspectives on global collaboration strategies and the impact on the innovative drug development and disruptive technology innovation.

Friday, September 29, Prallel Sessions

Pharma Investment Forum

Venture Forum, presented by SAPA, is the premier industry gathering connecting venture capitalists, corporate venture, angel investors, technology transfer professionals in top US universities, entrepreneurs of startups, incubators, legal counsel and researchers. If you are an investor looking for early assets, or an entrepreneur looking for funding, visibility and growth, or a researcher gaining insights into private equity world. This session is one event you won’t want to miss.


This session will feature one hour presentation to discuss new investment trend both in US and China, entrepreneur sharing their journey and experience.


Another hour will be venture panels, you will hear key issues facing investors and startups, successful cases and tips of fundraising sharing from those professionals. More importantly, you can connect with investors, startups and potential partners through this high level networking opportunity.

Business Development Forum

The importance of the business development and licensing (BD&L) function in the global biotech and biopharmaceutical industries has grown significantly over the past 20 years, as companies have sought to supplement their internal R&D with innovative products and technologies sourced through external licensing, joint ventures, acquisition of intellectual property rights, collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. These have required companies to employ BD&L executives to search, evaluate, negotiate and manage deals and alliances ranging from academic research institutes, to small biotechnology companies, and to the largest of the Big Pharma companies. The BD&L session at SAPA Annual Conference offers a unique opportunity to learn from industry experts on their valuable experience and latest industry trends. Don’t miss your chance to engage in discussions with speakers, hone your professional knowledge, and network with industry peers.

Global Collaboration with Outsourcing - Impact on Pharma Landscape

In the book, the World is Flat: A Brief History of the Twenty-First Century, Thomas Friedman argues that globalization makes the world a level playing field, where all competitors have equal opportunities.  Under such a competitive environment, traditional cost-saving outsourcing has evolved into a more advanced form of outsourcing, i.e., value-creating global collaboration, to drive new revenue, shorten time-to-market, lower the entry bar for new entrepreneur, and increase innovation.  In this session, we are fortunate to have several CEOs and executives from small to large CROs, and managers in charge of external collaboration from big pharma to share their strategy — how to build sustainable competitive advantages for growth with global collaboration in current pharmaceutical landscape.

Saturday, September 30, Parallel Sessions

Scientific Session: Immuno-Oncology

Immuno-oncology has revolutionized cancer treatment over the past decade and continues to yield new and exciting results. More and more new immunotherapies come into the clinics, from monoclonal antibody targeting the next generation of checkpoint inhibitors to oncolytic viral therapy, CAR-T cell therapy, and new cancer vaccines. The therapeutic approaches ranging from activating patients’ own immune system to attack cancer cells to neutralizing mechanism to regulate patient’s immune system, are increasingly implemented with much improved efficacy and unique safety profile which result in better quality of life for patients.

In this exciting scientific session, the leading experts in the immune-oncology field will present the latest progress in cancer immunotherapy and novel clinical study designs, as well as recent innovations in cutting edge technology in pharmaceutical industry.

Regulatory Session: Breakthrough Therapy and Its Applications

Since its implementation in 2012, breakthrough therapy (BT) designation has been playing an significant role in drug development. Breakthrough therapy designation expedites the development and review of drugs for serious or life-threatening conditions. Many companies applied for such designation.  So far, more than 100 BT designations have been granted, most of them in the immuno-oncology therapeutic and other unmet and serious disease areas.

This regulatory section will discuss the benefits of BT designation, its accordance criteria and application procedure.  Case studies will provide more sight on how to quality for the BT designation, how to apply for it and how it impacts the overall drug development and approvals.

Career Development Session: The Yin and Yang of Career Development

In Chinese philosophy, Yin and Yang describe how seemingly opposite or contrary forces may actually be complementary, interconnected, and interdependent in the natural world, and how they may give rise to each other as they interrelate to one another.  This concept can be readily applied to our journey on career planning, development, and advancement.  Each of us have our own strength and weakness, also we need to consciously and effectively engage the external world.  There are many examples of Yin and Yang balance or imbalance, and this session will dive deep and unveil the mask of career mysteries, ranging from different dimensions.  Come to be intrigued and stimulated. Either way, this session will make you think differently about yourself on how to live a more productive and fulfilling life.

IP Session: IP Protection, Licensing, Enforcement, or Challenge as Business Strategies in Pharmaceutical and Biotech Industries

Intellectual Property is the lifeblood of pharmaceutical/biotech industries, often the only asset of a start-up or emerging company, and sometimes the very reason that a pharmaceutical/biotech company exists. Therefore, IP protection is crucial to a company’s business success, IP licensing is often the core of business transactions, and IP right enforcement and/or challenge has become an integral part of business strategies. As a result, high-profile patent litigations or IP right declarations are taking place in higher frequencies, often before any commercial value of the technology at issue has been proven or realized, and 8- or 9-digit patent licensing fees in hot therapeutic areas or multi-billion dollar verdicts in high-profile patent lawsuits have become norms rather than exceptions.

This session will feature presentations and panel discussions by experienced in-house patent attorneys or IP managers as well as litigators and legal counsel from law firms on new development of pharmaceutical/biotech patent laws and trending legal strategies in IP protection, enforcement, licensing, and commercialization. Attendees will not only be able to gain valuable insight of various recent headline-grabbing patent lawsuits, but also be provided with opportunities to directly interact with the speakers to gain first-hand knowledge or information on any aspects of pharmaceutical patent laws.

The 2nd SAPA Annual Chinese CEO Forum – Stories Beyond the News

The SAPA Chinese CEO Forum is a unique platform for education, discussion and debate around current and future challenges and opportunities in the pharmaceutical industry.

Featured presentations will track the industry trends and provide projections and insights into future growth and development.  It will also provide participants with strategic information needed as portfolios continue to advance and evolve. Topics will include healthcare policy and regulatory reform, economic models impacting the industry, current challenges in recruitment and talent development, successful recent M&A between U.S. and Chinese companies, and opportunities in unique and beneficial partnership structures. There will be a round-table discussion following the presentations for in-depth interaction with participants.  You will get to hear true stories, opinions, and solutions from successful CEOs from both US and China; and have your questions answered by the industry leaders. 

2017 SAPA Startup-Venture Summit – Where Innovation Meets Capital


Are you passionate about starting your own business or building your own company? Would you like to bring your unique science/technology into real-life applications? What is most efficient way to “pitch” your business plans to investor? How to choose a startup company to work with, or to invest? What is the risk and benefit? …… If you are curious about any of these questions, don’t miss this brand new SAPA Startup-Venture summit.

In this year’s SAPA annual conference, “our courage” and “the cross US-China investment trend” lead us to setup a new session: Startup-Venture Summit. There will be industry leaders in investment (VC/PE) and BD to join us as panelists and advisers.  Ten early to middle stage biotech/life science startup companies will share their venture “pitch”. You are encouraged to participate and ask any questions you can’t wait to find out the answers.

This summit is designated to bridge startups and investments, to exchange innovative ideas and business plans, to analyze the pros and cons of a startup, to help you judge if you are ready to be your own boss, to inspire more forthcoming creative thoughts and executions. Come and join this exciting half-day event and be prepared, because it may forever change our lives!

Tap “Read more/阅读原文” to register!

首页 - SAPA 的更多文章: